Bioxyne
ASX:BXN
$ 0,06
$0,00 (0,00%)
0,06 $
$0,00 (0,00%)
End-of-day quote: 04/08/2026

Bioxyne Stock Value

The analyst rating for Bioxyne is currently sf_Data Unavailable.
-

Bioxyne Company Info

EPS Growth 5Y
0,00%
Market Cap
$0,14 B
Long-Term Debt
$0,00 B
Quarterly earnings
05/28/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Founded
1998
Industry
Country
Website
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Bioxyne’s Price Target has risen from $0,00 to $0,06 - a 100,00% increase.

Top growth stocks in the health care sector (5Y.)

What does Bioxyne do?

Bioxyne Limited specializes in the development, manufacturing, and distribution of health and wellness products, focusing on probiotics, plant-based wellness supplements, and functional foods. Business Segments The Company operates through several distinct business segments to address diverse consumer needs: Probiotic Wholesale Business: Featuring the proprietary probiotic strain Lactobacillus fermentum VRI-003 (PCC), this segment ensures high safety and efficacy through a manufacturing partn...
×